Celera Revenues Drop 21 Percent in Q2

Offsetting increased revenues in its molecular diagnostics business, Celera's laboratory service and corporate revenues dropped.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories